Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 2/2005

01-02-2005 | Review

Cardiovascular complications in pediatric end-stage renal disease

Authors: Rulan S. Parekh, Samuel S. Gidding

Published in: Pediatric Nephrology | Issue 2/2005

Login to get access

Abstract

Mortality from end-stage renal disease (ESRD) is often due to cardiac causes. Although cardiovascular complications of ESRD have long been recognized, only recently has the presence of traditional cardiovascular risk factors been associated with late cardiovascular complications. This review presents a history of cardiac involvement in ESRD, the pathophysiology of accelerated atherosclerosis and left ventricular hypertrophy, and a summary of the literature on cardiovascular risk assessment in children. Techniques for non-invasive assessment of cardiac end-organ injury are also discussed. Recommendations for monitoring of risk factors and treatment in the pediatric ESRD population are presented.
Literature
1.
Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191–197CrossRefPubMed
2.
3.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154–2169CrossRefPubMed
4.
Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34:125–134PubMed
5.
Alpert MA, Ravenscraft MD (2003) Pericardial involvement in end-stage renal disease. Am J Med Sci 325:228–236PubMed
6.
Scharer K, Schmidt KG, Soergel M (1999) Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 13:951–965CrossRefPubMed
7.
Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318–323CrossRefPubMed
8.
Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ (2000) Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14:105–110CrossRefPubMed
9.
Kari JA, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468–472PubMed
10.
Fine A (2002) Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 61:615–620CrossRefPubMed
11.
Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59:407–414CrossRefPubMed
12.
Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Scharer K (1993) Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease. Pediatr Res 34:772–776PubMed
13.
Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648–653CrossRefPubMed
14.
15.
Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041–2047
16.
London G (2003) Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 14 [Suppl 4]:S305–S309
17.
Milliner DS, Morgenstern BZ, Murphy M, Gonyea J, Sterioff S (1994) Lipid levels following renal transplantation in pediatric recipients. Transplant Proc 26:112–114PubMed
18.
Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszynska J, Jobs K, Boguszewska-Baczkowska A, Wawer ZT (2001) Patient survival and causes of death on hemodialysis and peritoneal dialysis—single-center study. Pediatr Nephrol 16:996–1001CrossRefPubMed
19.
Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483CrossRefPubMed
20.
Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105CrossRefPubMed
21.
Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638–647CrossRefPubMed
22.
Moe SM, Duan D, Doehle BP, O’Neill KD, Chen NX (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003–1011CrossRefPubMed
23.
Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864–868CrossRefPubMed
24.
Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902CrossRefPubMed
25.
Ulmer H (1978) Cardiovascular impairment and physical working capacity in children with chronic renal failure. Acta Paediatr Scand 67:43–48PubMed
26.
Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG (1993) Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child 68:637–643PubMed
27.
Litwin M, Kawalec W, Latoszynska J, Grenda R, Smirska E (1994) Cardiac systolic and diastolic function in children on hemodialysis and continuous ambulatory peritoneal dialysis. Contrib Nephrol 106:114–118PubMed
28.
Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR (1996) Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50:998–1006PubMed
29.
Mitsnefes M, Ho PL, McEnery PT (2003) Hypertension and progression of chronic renal insufficiency in children: A Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14:2618–2622CrossRefPubMed
30.
Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adults. The 2001NAPRTCS Annual Report. Pediatr Nephrol 17:656–663CrossRefPubMed
31.
Parekh RS, Ni W, Fivush BA, Klag MJ (2001) Prevalence of traditional cardiovascular risk factors in the Dialysis Mortality and Morbidity Special Study (DMMS) among different age groups: a nationally representative sample of the US ESRD population. J Am Soc Nephrol 12:236ACrossRef
32.
National Kidney Foundation (2003) K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41 [Suppl 3]:S1–S92
33.
Bostom AG, Kronenberg F, Jacques PF, Kuen E, Ritz E, Konig P, Kraatz G, Lhotta K, Mann JF, Muller GA, Neyer U, Riegel W, Schwenger V, Riegler P, Selhub J (2001) Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis 159:219–223CrossRefPubMed
34.
Merouani A, Lambert M, Delvin EE, Genest J Jr, Robitaille P, Rozen R (2001) Plasma homocysteine concentration in children with chronic renal failure. Pediatr Nephrol 16:805–811CrossRefPubMed
35.
Lilien M, Duran M, Van Hoeck K, Poll-The BT, Schroder C (1999) Hyperhomocyst(e)inaemia in children with chronic renal failure. Nephrol Dial Transplant 14:366–368
36.
Stenvinkel P, Pecoits-Filho R, Lindholm B (2003) Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 14:1927–1939CrossRefPubMed
37.
Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D (2003) Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143:653–657CrossRefPubMed
38.
Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607–617PubMed
39.
Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131–2138PubMed
40.
Gidding SS (2002) The aging of the cardiovascular system: when should children be treated like adults? J Pediatr 141:159–161CrossRefPubMed
41.
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed
42.
43.
Aggoun Y, Niaudet P, Laffont A, Sidi D, Kachaner J, Bonnet D (2000) Cardiovascular impact of end-stage renal insufficiency in children undergoing hemodialysis. Arch Mal Coeur Vaiss 93:1009–1013PubMed
44.
Hampl H, Sternberg C, Berweck S, Lange D, Lorenz F, Pohle C, Riedel E, Gogoll L, Hennig L (2002) Regression of left ventricular hypertrophy in hemodialysis patients is possible. Clin Nephrol 58 [Suppl 1]:S73–S96
45.
Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM, Lemes V (1999) Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 18:269–274
46.
National Cholesterol Education Program (1992) Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89:525–584PubMed
47.
American Diabetes Association (2003) Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 26:2194–2197PubMed
48.
Group KDOQIKD (2003), K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41 [Suppl 3]:S1–S91
49.
Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr, Levin A, Masri B, Parekh R, Wanner C, Wheeler DC, Wilson PW (2004) Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 [Suppl 7]:13–53
50.
Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE (2002) Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105:1810–1815CrossRefPubMed
51.
Bostom AG, Kronenberg F, Gohh RY, Schwenger V, Kuen E, Konig P, Kraatz G, Lhotta K, Mann JF, Muller GA, Neyer U, Riegel W, Riegler P, Ritz E, Selhub J (2001) Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis 156:227–230CrossRefPubMed
Metadata
Title
Cardiovascular complications in pediatric end-stage renal disease
Authors
Rulan S. Parekh
Samuel S. Gidding
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 2/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1664-0

Other articles of this Issue 2/2005

Pediatric Nephrology 2/2005 Go to the issue

Editorial Commentary

A realistic chance for gene therapy in the near future

Book Review

Ronald J. Portman, Jonathan M. Sorof, Julie R. Ingelfinger (eds): Pediatric Hypertension

Book Review

Claudio Ronco, Paolo M. Ghezzi, Nicholas A. Hoenich, Piergiuseppe Delfino: Membranes and filters for hemodialysis: database 2004.

Brief Report

Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schönlein purpura treated with plasmapheresis

Letter to the Editors

Decrease of thrombomodulin contributes to the procoagulant state of endothelium in haemolytic uraemic syndrome

Brief Report

Marked renal damage in a child with hydronephrosis infected by Trichosporon asahii